Coty Inc. — Form 10-Q Summary
Reporting period: Fiscal second quarter and first six months ended December 31, 2023. Coty manufactures and sells fragrance, color cosmetics, and skin and body care products globally. Comparisons below are with the corresponding prior-year periods; dollar amounts are in millions unless stated otherwise.
Financial performance
| Metric | Three months | Six months |
|---|---|---|
| Net revenue | $1,727.6, up 13% reported and 14% excluding prior-year Russia sales | $3,369.0, up 16% reported and 17% excluding prior-year Russia sales |
| Gross margin | 65.1%, down about 40 basis points | 64.3%, down about 50 basis points |
| Operating income / margin | $236.7 / 13.7%, versus $199.3 / 13.1% | $434.2 / 12.9%, versus $371.2 / 12.7% |
| Net income attributable to Coty Inc. | $180.9, versus $238.3 | $182.5, versus $366.9 |
| GAAP diluted EPS | $0.20, versus $0.27 | $0.20, versus $0.42 |
| Operating cash flow | Not presented separately in the filing excerpt | $608.1, versus $645.4 |
Segments: Prestige revenue rose 17% in the quarter and 20% for six months; Consumer Beauty revenue rose 7% and 8%, respectively. Six-month operating income increased to $422.2 for Prestige and $92.4 for Consumer Beauty. Quarterly operating margins were 17.9% for Prestige and 10.0% for Consumer Beauty.
Adjusted, non-GAAP results: Quarterly adjusted operating income was $309.3, with a 17.9% margin; adjusted EBITDA was $366.4, with a 21.2% margin. For six months, adjusted operating income was $611.5, with an 18.2% margin, and adjusted EBITDA was $726.7, with a 21.6% margin. Adjusted net income attributable to Coty Inc. was $229.1 for the quarter and $303.2 for six months. These measures exclude specified items and should be considered alongside GAAP results.
Cash, liquidity, and debt: At December 31, cash and cash equivalents were $450.0, with $33.5 of restricted cash. Total debt was $3,761.8, down from $4,281.6 at June 30; long-term debt, net, was $3,682.9. The company reported covenant compliance. Six-month investing cash outflow was $119.4, primarily reflecting $121.1 in capital expenditures; financing cash outflow was $285.9. Operating cash flow was lower year over year, mainly due to working-capital movements.
Changes and notable items
- Revenue growth was driven by prestige fragrances, pricing and mix, improved product availability, and travel retail and digital sales. China was a notable exception, with macroeconomic conditions affecting some brands.
- Gross margin declined despite pricing benefits, principally due to higher excess and obsolescence costs and designer license fees; lower freight and manufacturing costs partly offset these effects. SG&A declined as a share of revenue, supporting higher operating margins.
- Reported net income fell despite higher operating income. Other income declined to $80.8 from $141.9 for the quarter and to $4.2 from $240.1 for six months, largely reflecting smaller fair-value gains on Coty’s Wella investment versus the prior year. The six-month effective tax rate rose to 36.4% from 22.4%, including a $24.3 expense from revaluing deferred tax liabilities after a Swiss tax-rate increase.
- Coty issued 33 million common shares in a global offering, generating approximately $348 million in proceeds, primarily used to repay debt. It issued new secured notes and refinanced revolving facilities, repaid its Term B facility and Brazilian credit facility, and completed tenders for 2026 notes.
Outlook, risks, and contingencies
- Management expects fiscal 2024 revenue growth in the high single digits to low double digits, excluding foreign exchange, the Russia market exit, and early termination of the Lacoste fragrance license. This is a forward-looking expectation, not a guarantee.
- Management reported improving order fill rates, close to pre-COVID service levels in the second quarter, and expects inflationary pressure overall to continue easing, though some costs, including labor, may remain affected.
- Risks include changing consumer demand and macroeconomic conditions in China; foreign exchange and inflation; supply-chain disruption and the Red Sea conflict; execution of transformation and growth initiatives; competition, licensing, cybersecurity, and regulatory risks; and the ability to reduce debt and maintain liquidity.
- Coty’s Wella investment was valued at $1,077.0 using Level 3 inputs, including projected growth, discount rates, and valuation multiples. A proposed $150 million sale of a 3.6% stake was terminated; Coty retained a 25.9% stake.
- Brazilian tax assessments remain contested. The filing lists open assessments totaling approximately $407.8 million, including interest and penalties; Coty says it has meritorious defenses and has not accrued a loss because it does not consider a loss probable. Surety bonds of approximately $87.3 million were in place. The filing also discusses litigation, including consumer and talc-related matters, whose outcomes cannot be assured.
- Coty expects to pay approximately $200 million to physically settle a forward repurchase contract in fiscal Q3 in exchange for about 27 million shares. It made no share repurchases under its program during the quarter. Common-stock dividends remain suspended; preferred-stock dividends continue subject to board declaration.
Most important facts for investors to verify
- Whether revenue momentum, especially in Prestige, and improved fill rates continue, and whether weakness in China or license changes offset growth elsewhere.
- How much of operating performance is reflected in GAAP results versus adjusted measures, and how Wella fair-value movements, restructuring, and tax items affect reported earnings.
- Debt reduction, interest costs, covenant headroom, cash generation, and the cash and dilution effects of the planned forward repurchase settlement.
- Whether the fiscal 2024 revenue outlook remains achievable amid geopolitical, supply-chain, foreign-exchange, and consumer-demand risks.
- Developments in Brazilian tax disputes and other legal contingencies, and changes in the valuation assumptions for the Wella investment.